Skip to Content

Proto Script Pharmaceutical Corp PSCR

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PSCR is trading at a 289% premium.
Price
$0.00
Fair Value
$6.13
Uncertainty
Extreme
1-Star Price
$5.57
5-Star Price
$2.90
Economic Moat
Rzyfzb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PSCR is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.01
Market Cap
$9,828.00
Volume/Avg
1,000 / 152,300

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.
Sector
Industrials
Industry
Specialty Business Services
Stock Style Box
Total Number of Employees
13

Valuation

Metric
PSCR
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
PSCR

Financial Strength

Metric
PSCR
Quick Ratio
0.10
Current Ratio
0.11
Interest Coverage
Quick Ratio
PSCR

Profitability

Metric
PSCR
Return on Assets (Normalized)
−702.21%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
PSCR
See how this stock stacks up to its competitors with Morningstar Investor

Specialty Business Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
RELX PLC
RLXXF
Lxjqv$85.1 Bil
RELX PLC ADR
RELX
ZgsfmfjdClqhh$85.1 Bil
Thomson Reuters Corp
TRI
HmykbqwJgdnfst$74.9 Bil
Cintas Corp
CTAS
RmjbnrypYmct$72.1 Bil
Copart Inc
CPRT
TpfvpcmjGmtd$52.8 Bil
Wolters Kluwer NV ADR
WTKWY
YlglvddzTgr$39.4 Bil
Wolters Kluwer NV
WOLTF
Cbrmm$39.4 Bil
Global Payments Inc
GPN
MqhxqfccSxqjfsq$23.5 Bil
RB Global Inc
RBA
QvzrzxbvWxndh$14.7 Bil
Rentokil Initial PLC ADR
RTO
RhlsvlfwDfwy$14.5 Bil

Sponsor Center